Attached files

file filename
10-Q - FORM 10-Q - SYNERGY PHARMACEUTICALS, INC.a2195509z10-q.htm
EX-31.2 - EXHIBIT 31.2 - SYNERGY PHARMACEUTICALS, INC.a2195509zex-31_2.htm
EX-31.1 - EXHIBIT 31.1 - SYNERGY PHARMACEUTICALS, INC.a2195509zex-31_1.htm
EX-32.1 - EXHIBIT 32.1 - SYNERGY PHARMACEUTICALS, INC.a2195509zex-32_1.htm

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 32.2


CERTIFICATION OF SENIOR VICE PRESIDENT, FINANCE
SYNERGY PHARMACEUTICALS, INC.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2009
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

        I am the Senior Vice President, Finance of Synergy Pharmaceuticals, Inc., a Florida corporation (the "Company"). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended September 30, 2009 and filed with the Securities and Exchange Commission ("Form 10-Q").

        Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
   
Date: November 16, 2009   /s/ BERNARD F. DENOYER

Bernard F. Denoyer
Senior Vice President, Finance



QuickLinks

CERTIFICATION OF SENIOR VICE PRESIDENT, FINANCE SYNERGY PHARMACEUTICALS, INC. FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2009 PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002